Mizuho Boosts Xylem (NYSE:XYL) Price Target to $135.00

Xylem (NYSE:XYL) had its price objective upped by Mizuho from $110.00 to $135.00 in a report issued on Friday morning, Benzinga reports. They currently have a neutral rating on the industrial products company’s stock.

Other analysts also recently issued reports about the company. Stifel Nicolaus upped their price objective on Xylem from $136.00 to $150.00 and gave the company a buy rating in a research report on Wednesday, February 7th. BNP Paribas assumed coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an outperform rating and a $150.00 target price on the stock. Oppenheimer lifted their price target on shares of Xylem from $133.00 to $142.00 and gave the stock an outperform rating in a report on Thursday, April 18th. Citigroup upped their price objective on shares of Xylem from $126.00 to $139.00 and gave the company a neutral rating in a research note on Monday, April 8th. Finally, Robert W. Baird raised their target price on shares of Xylem from $151.00 to $155.00 and gave the stock an outperform rating in a research report on Friday. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, Xylem has an average rating of Moderate Buy and an average target price of $140.70.

Xylem Price Performance

Shares of NYSE XYL opened at $137.21 on Friday. The company has a current ratio of 1.67, a quick ratio of 1.30 and a debt-to-equity ratio of 0.19. The company’s 50-day moving average price is $128.64 and its 200 day moving average price is $115.54. Xylem has a 52 week low of $87.59 and a 52 week high of $138.46. The stock has a market cap of $33.26 billion, a price-to-earnings ratio of 48.83, a PEG ratio of 2.69 and a beta of 1.08.

Xylem (NYSE:XYL) last released its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. During the same period in the prior year, the business earned $0.72 earnings per share. The company’s quarterly revenue was up 40.4% on a year-over-year basis. As a group, research analysts forecast that Xylem will post 4.24 earnings per share for the current fiscal year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is 51.25%.

Insider Transactions at Xylem

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Institutional Trading of Xylem

Hedge funds have recently made changes to their positions in the company. Bruce G. Allen Investments LLC acquired a new stake in Xylem during the 4th quarter valued at $27,000. NBC Securities Inc. purchased a new stake in shares of Xylem during the third quarter worth about $38,000. FinTrust Capital Advisors LLC lifted its stake in shares of Xylem by 170.9% in the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after acquiring an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its stake in shares of Xylem by 184.9% in the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after acquiring an additional 220 shares in the last quarter. Finally, Orion Capital Management LLC purchased a new position in Xylem in the third quarter valued at about $48,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.